NO990498D0 - 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon - Google Patents
19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjonInfo
- Publication number
- NO990498D0 NO990498D0 NO990498A NO990498A NO990498D0 NO 990498 D0 NO990498 D0 NO 990498D0 NO 990498 A NO990498 A NO 990498A NO 990498 A NO990498 A NO 990498A NO 990498 D0 NO990498 D0 NO 990498D0
- Authority
- NO
- Norway
- Prior art keywords
- cholansteroids
- change
- hypothalamic function
- human hypothalamic
- neurochemical initiators
- Prior art date
Links
- 230000002267 hypothalamic effect Effects 0.000 title 1
- 239000003999 initiator Substances 0.000 title 1
- 230000001722 neurochemical effect Effects 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/027—Making masks on semiconductor bodies for further photolithographic processing not provided for in group H01L21/18 or H01L21/34
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Manufacturing & Machinery (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Physical Education & Sports Medicine (AREA)
- Computer Hardware Design (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/660,804 US5922699A (en) | 1996-06-07 | 1996-06-07 | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| PCT/US1997/009992 WO1997046574A1 (fr) | 1996-06-07 | 1997-06-09 | Steroïdes de 19-nor-cholane utiles comme initiateurs neurochimiques d'une modification de la fonction hypothalamique humaine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO990498D0 true NO990498D0 (no) | 1999-02-03 |
| NO990498L NO990498L (no) | 1999-02-03 |
Family
ID=24651031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO990498A NO990498L (no) | 1996-06-07 | 1999-02-03 | 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US5922699A (fr) |
| EP (1) | EP0948521A4 (fr) |
| KR (1) | KR20010013101A (fr) |
| AU (1) | AU732960B2 (fr) |
| BG (1) | BG62936B1 (fr) |
| CA (1) | CA2258177C (fr) |
| HU (1) | HUP9903432A3 (fr) |
| NO (1) | NO990498L (fr) |
| NZ (1) | NZ333548A (fr) |
| PL (1) | PL331522A1 (fr) |
| WO (1) | WO1997046574A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922699A (en) | 1996-06-07 | 1999-07-13 | Pherin Corporation | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| AU726625B2 (en) * | 1996-07-23 | 2000-11-16 | Pherin Pharmaceuticals, Inc. | Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety |
| FR2791572A1 (fr) * | 1999-03-31 | 2000-10-06 | Adir | Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables |
| US6806293B1 (en) * | 2001-03-12 | 2004-10-19 | Darley Pharmaceuticals Ltd | Use of pheromone compounds having MAP kinase modulating activity |
| AU2002316146B2 (en) * | 2001-05-15 | 2007-09-06 | Psychogenics Inc. | Systems and methods for monitoring behaviour informatics |
| DE10335845B4 (de) * | 2003-05-09 | 2006-08-31 | Müller, Martina, Dr.med. | Pheromone als Antikrebsmittel |
| EP1789056A1 (fr) * | 2004-06-29 | 2007-05-30 | Jado Technologies GmbH | Utilisation de compositions pharmaceutiques derivees de steroides pour le traitement de troubles associes a des processus pathologiques dans les radeaux lipidiques |
| US20070048230A1 (en) * | 2005-08-24 | 2007-03-01 | Walter Parsadayan | Pheromone compositions and methods |
| DE102020204509A1 (de) | 2020-04-07 | 2021-10-07 | Henkel Ag & Co. Kgaa | Waschmittel mit Pheromonen |
| DE102020204506A1 (de) | 2020-04-07 | 2021-10-07 | Henkel Ag & Co. Kgaa | Weichspüler mit Pheromonen |
| DE102020204507A1 (de) | 2020-04-07 | 2021-10-07 | Henkel Ag & Co. Kgaa | Weichspüler mit aphrodisierend wirkenden Duftstoffen |
| DE102020204505A1 (de) | 2020-04-07 | 2021-10-07 | Henkel Ag & Co. Kgaa | Wasch-/Pflegeartikel umfassend Pheromone |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH430710A (de) * | 1958-04-12 | 1967-02-28 | Philips Nv | Verfahren zur Herstellung neuer Steroide |
| US3492318A (en) | 1968-01-22 | 1970-01-27 | Syntex Corp | Cyclopropenyl androstanes |
| US3946052A (en) * | 1975-06-16 | 1976-03-23 | Stanford Research Institute | 19-Norpregna- 1,3,5(10)-trien-3-ol and loweralkyl homologs thereof having postcoital antifertility activity |
| US5155045A (en) | 1985-01-25 | 1992-10-13 | Trustees Of The University Of Penn. | Use of male essence to alter female endocrine response |
| US5223492A (en) * | 1987-10-27 | 1993-06-29 | Nasraoui Nejib M | Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them |
| FR2637803B1 (fr) * | 1988-10-19 | 1993-07-09 | Ire Celltarg Sa | Ligands specifiques de recepteurs d'hormones steroides estrogenes et progestagenes, application et produits intermediaires de synthese |
| JP2578369B2 (ja) | 1989-05-09 | 1997-02-05 | ポーラ化成工業株式会社 | 芳香組成物 |
| US5969168A (en) * | 1991-01-07 | 1999-10-19 | Pherin Corporation | Androstanes for inducing hypothalamic effects |
| US5272134A (en) * | 1992-03-24 | 1993-12-21 | Erox Corporation | Fragrance compositions and other compositions which contain human pheromones |
| EP0701444B1 (fr) * | 1993-05-24 | 2010-04-07 | Purdue Pharma Ltd. | Procedes et compositions induisant le sommeil |
| HUT74171A (en) * | 1993-06-15 | 1996-11-28 | Pherin Corp | Estrene steroids as neurochemical initiators of change in human hypothalamic function and pharmaceutical compositions containing them |
| FI956029L (fi) * | 1993-06-15 | 1996-02-14 | Pherin Corp | Androstaanisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät |
| EP0738275B9 (fr) * | 1994-01-06 | 2001-03-21 | Sri International | Composes antiandrogenes, preparations pharmaceutiques associees et leurs modes d'utilisation |
| US6066627A (en) * | 1994-08-04 | 2000-05-23 | Pherin Corporation | Steroids as neurochemical initiators of change in human blood levels of LH |
| US5563131A (en) * | 1994-08-04 | 1996-10-08 | Pherin Corporation | Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| US5792757A (en) * | 1994-08-04 | 1998-08-11 | Pherin Pharmaceuticals | 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function |
| WO1996010032A1 (fr) * | 1994-09-29 | 1996-04-04 | Pherin Corporation | Nouveaux estrenes exerçant une action sur l'hypothalamus |
| ATE204509T1 (de) | 1995-06-07 | 2001-09-15 | Usf Filtration & Separations | Mikrofiltrationsmembranen mit einer hohen porendichte und einer gemischten isotropen und anisotropen struktur |
| US5922699A (en) | 1996-06-07 | 1999-07-13 | Pherin Corporation | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| AU726625B2 (en) * | 1996-07-23 | 2000-11-16 | Pherin Pharmaceuticals, Inc. | Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety |
-
1996
- 1996-06-07 US US08/660,804 patent/US5922699A/en not_active Expired - Lifetime
-
1997
- 1997-06-09 WO PCT/US1997/009992 patent/WO1997046574A1/fr not_active Ceased
- 1997-06-09 EP EP97928921A patent/EP0948521A4/fr not_active Withdrawn
- 1997-06-09 AU AU33073/97A patent/AU732960B2/en not_active Ceased
- 1997-06-09 HU HU9903432A patent/HUP9903432A3/hu unknown
- 1997-06-09 NZ NZ333548A patent/NZ333548A/en unknown
- 1997-06-09 PL PL97331522A patent/PL331522A1/xx unknown
- 1997-06-09 CA CA002258177A patent/CA2258177C/fr not_active Expired - Fee Related
- 1997-06-09 KR KR19997011080A patent/KR20010013101A/ko not_active Withdrawn
- 1997-06-09 US US08/871,296 patent/US6432938B1/en not_active Expired - Fee Related
-
1999
- 1999-01-07 BG BG103060A patent/BG62936B1/bg unknown
- 1999-02-02 US US09/241,594 patent/US6437156B1/en not_active Expired - Fee Related
- 1999-02-03 NO NO990498A patent/NO990498L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BG62936B1 (bg) | 2000-11-30 |
| PL331522A1 (en) | 1999-07-19 |
| BG103060A (en) | 1999-10-29 |
| WO1997046574A1 (fr) | 1997-12-11 |
| HUP9903432A2 (hu) | 2000-03-28 |
| US6432938B1 (en) | 2002-08-13 |
| NO990498L (no) | 1999-02-03 |
| KR20010013101A (ko) | 2001-02-26 |
| CA2258177C (fr) | 2007-05-08 |
| US6437156B1 (en) | 2002-08-20 |
| CA2258177A1 (fr) | 1997-12-11 |
| EP0948521A4 (fr) | 2007-01-31 |
| AU732960B2 (en) | 2001-05-03 |
| EP0948521A1 (fr) | 1999-10-13 |
| AU3307397A (en) | 1998-01-05 |
| US5922699A (en) | 1999-07-13 |
| NZ333548A (en) | 2000-06-23 |
| HUP9903432A3 (en) | 2000-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS4970A (is) | Setnar 6,6-heteró-bísýklískar afleiður | |
| IS1995B (is) | Tríazól afleiður, gagnlegar í meðhöndlun | |
| DE69838405D1 (de) | Mikrostrukturierte, kosmetisch verträgliche Zusamensetzungen | |
| IT1285134B1 (it) | Compressore alternativo. | |
| ATE246199T1 (de) | 3-descladinose-2,3-anhydroerythromycin-derivate | |
| NO990498D0 (no) | 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon | |
| NO960499L (no) | Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner | |
| BR9506389B1 (pt) | composto de silìcio, e, composição dietética, cosmética e terapêutica. | |
| NO982304L (no) | 25-Hydroksy-16-ene-26,27-bishomo-cholecalciferoler | |
| ATE198192T1 (de) | Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung | |
| EP0965340A4 (fr) | Preparation dermatologique | |
| NO970472L (no) | Preganer og cholaner som neurokjemiske intiatorer av forandring i hypotalamusfunksjon | |
| NL1000591C2 (nl) | Weefsel. | |
| ATE240941T1 (de) | 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate | |
| FI972860A0 (fi) | Roottoreita | |
| ES1032571Y (es) | Gafa, | |
| FR2752699B1 (fr) | Boitier, du type boitier de maquillage | |
| FI972885A0 (fi) | Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik | |
| FI951664A0 (fi) | Oeverkast foer med armstoed foersedda soffor, faotoeljer eller motsvarande | |
| ES1035559Y (es) | Carteraporta-objeto ocultable. | |
| FI962387A0 (fi) | Foerfarande foer framstaellning av 1,4-butandiol | |
| FI962118A0 (fi) | Foerbaettrad anordning foer behandling av roekgaser, saerskilt avgaser | |
| FI1920U1 (fi) | Torkugn, foer torkning av maolade eller pao annat liknande saett behandlade delar | |
| ES1032559Y (es) | Perfeccionamientos introducidos en la construccion de edificios. | |
| FI1391U1 (fi) | Utrymme, saosom bastu av elementkonstruktion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |